99% Savings - Buy Just @1 Rs X
Lipigo F 5 Tablet is a prescription medicine that is available as a Tablet. Lipigo F 5 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Lipigo F 5 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Lipigo F 5 Tablet also has some side effects, the most common being Nausea or vomiting, Headache, Constipation. Apart from the aforementioned side effects, Lipigo F 5 Tablet can also lead to other problems, which have been listed below. These side effects of Lipigo F 5 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Lipigo F 5 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Lipigo F 5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lipigo F 5 Tablet related warnings section.
Lipigo F 5 Tablet is contraindicated in people with pre-existing medical conditions like Diabetes as it can result in adverse effects.
Besides this, Lipigo F 5 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Lipigo F 5 Tablet is not safe while driving, and is is not addictive in nature.
Lipigo F 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Lipigo F 5 Tablet safe for pregnant women?
Lipigo F can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Lipigo F right away. Take your doctor's advice before taking it again.
Is the use of Lipigo F 5 Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Lipigo F. Immediately discontinue Lipigo F if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Lipigo F 5 Tablet on the Kidneys?
Lipigo F rarely harms the kidneys.
What is the effect of Lipigo F 5 Tablet on the Liver?
Side effects of Lipigo F rarely affect the liver.
What is the effect of Lipigo F 5 Tablet on the Heart?
There may be an adverse effect on the heart after taking Lipigo F. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Lipigo F 5 Tablet unless your doctor advises you to do so -
Is this Lipigo F 5 Tablet habit forming or addictive?
Lipigo F 5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Lipigo F 5 Tablet, you should not drive or work on any heavy machine, as Lipigo F 5 Tablet can make you drowsy.
Is it safe?
Lipigo F 5 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Lipigo F 5 Tablet for mental disorders.
Interaction between Food and Lipigo F 5 Tablet
There isn't any research available on the side effects of taking Lipigo F 5 Tablet with food.
Interaction between Alcohol and Lipigo F 5 Tablet
Information about the interaction of Lipigo F 5 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650